MoneyWorks4Me

Fredun Pharmaceuticals informs about board meeting

09 Dec 2023 Evaluate

Fredun Pharmaceuticals has informedthat the meeting of the Board of Directors of the Company is scheduled on16/12/2023 ,inter alia, to consider and approve for fund raising upto Rs. 120crores by way of further public offer, right issue, ADR/GDR/FCCB, QIP, Debtissue, preferential issue or any other method.

The above information is a part of company’s filingssubmitted to BSE.

Fredun Pharma Share Price

1453.35 -94.40 (-6.10%)
17-Aug-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1882.50
Dr. Reddys Labs. 1192.00
Cipla 1430.00
Lupin 2259.20
Zydus Lifesciences 1132.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: